4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-26-032048
Director sold 8,400 shares at an average $78.50 ($659,387)
- Director acquired 8,400 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
STARR CHRISTOPHER M · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,400 | $0.01 | $42 | 13,573 | D |
| 2026-10-01 | Sale : show line 2 in the form 10b5-1 | −4,631 | $78.09 | $361,635 | 8,942 | D |
| 2026-10-01 | Sale : show line 3 in the form 10b5-1 | −2,970 | $78.82 | $234,095 | 5,972 | D |
| 2026-10-01 | Sale : show line 4 in the form 10b5-1 | −799 | $79.67 | $63,656 | 5,173 | D |
| Open-market sales · 8,400 sh · avg $78.50 · $659,387 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-01 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option | −8,400 | 8,400 | D |
Loading xslF345X06/rdgdoc.xml…